Surgical outcomes in patients with locally advanced gastric cancer treated with S-1 and oxaliplatin as neoadjuvant chemotherapy

被引:0
|
作者
Daofu Feng
Meiha Leong
Ting Li
Lin Chen
Tao Li
机构
[1] General Hospital of Chinese PLA,Department of General Surgery
[2] General Hospital of Tianjin Medical University,Department of General Surgery
[3] Kiang Wu Hospital,Department of Surgery
来源
World Journal of Surgical Oncology | / 13卷
关键词
Gastric cancer; D2 lymphadenectomy; Pathological complete response; Complications; Neoadjuvant chemotherapy;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [21] S-1 Combined with Oxaliplatin as First Line Chemotherapy for Chinese Advanced Gastric Cancer Patients
    Liu, Bixia
    Ying, Jieer
    Luo, Cong
    Xu, Qi
    Zhu, Liming
    Zhong, Haijun
    HEPATO-GASTROENTEROLOGY, 2012, 59 (114) : 649 - 653
  • [22] Neoadjuvant chemotherapy with S-1 and surgical resection for a mucinous gastric cancer with peritoneal dissemination
    Hamada M.
    Tsuji A.
    Iwata J.
    Nishioka Y.
    Ozaki K.
    Shima Y.
    Horimi T.
    Gastric Cancer, 2005, 8 (1) : 50 - 54
  • [23] Prognostic factors associated with locally advanced gastric cancer patients treated with neoadjuvant chemotherapy followed by surgical resection
    Sun, Yongkun
    Yang, Lin
    Wang, Chengfeng
    Zhao, Dongbing
    Cai, Jianqiang
    Li, Wenbin
    Zhang, Wen
    Huang, Jing
    Zhou, Aiping
    ONCOTARGET, 2017, 8 (43) : 75186 - 75194
  • [24] A phase I study of docetaxel/oxaliplatin/S-1 (DOS) combination neoadjuvant chemotherapy for patients with locally advanced adenocarcinoma of the esophagogastric junction
    Hosoda, Kei
    Azuma, Mizutomo
    Katada, Chikatoshi
    Ishido, Kenji
    Niihara, Masahiro
    Ushiku, Hideki
    Sakuraya, Mikiko
    Washio, Marie
    Wada, Takuya
    Watanabe, Akinori
    Harada, Hiroki
    Tanabe, Satoshi
    Koizumi, Wasaburo
    Yamashita, Keishi
    Hiki, Naoki
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2020, 25 (06) : 1090 - 1097
  • [25] The predictors of response to neoadjuvant chemotherapy in patients with locally advanced gastric cancer
    Qu, Jianjun
    Qu, Xiangyang
    CANCER BIOMARKERS, 2016, 17 (01) : 49 - 54
  • [26] S-1 AND OXALIPLATIN REGIMEN NEOADJUVANT CHEMOTHERAPY FOLLOWED BY SURGERY FOR RESECTABLE ADVANCED GASTRIC CANCER WITH MULTIPLE LYMPH-NODE METASTASIS
    Udaka, T.
    Nishiyama, T.
    Watanabe, N.
    Endou, I.
    Yoshida, O.
    Asano, H.
    Kubo, M.
    WORLD CANCER RESEARCH JOURNAL, 2022, 9
  • [27] Pathologic and Oncologic Outcomes in Locally Advanced Gastric Cancer with Neoadjuvant Chemotherapy or Chemoradiotherapy
    An, Ji Yeong
    Kim, Hyoung-Il
    Cheong, Jae-Ho
    Hyung, Woo Jin
    Kim, Choong Bae
    Noh, Sung Noon
    YONSEI MEDICAL JOURNAL, 2013, 54 (04) : 888 - 894
  • [28] A Prospective Multicenter Phase II Study on the Feasibility and Efficacy of S-1 and Oxaliplatin Neoadjuvant Chemotherapy for Locally Advanced Rectal Cancer
    Sakamoto, Yoshiyuki
    Morohashi, Hajime
    Miura, Takuya
    Tsutsumi, Shinji
    Takahashi, Seiji
    Hirama, Kimiaki
    Wakiya, Taiichi
    Hakamada, Kenichi
    DISEASES OF THE COLON & RECTUM, 2022, 65 (05) : 663 - 671
  • [29] Feasibility of neoadjuvant S-1 and oxaliplatin followed by surgery for resectable advanced gastric adenocarcinoma
    Honma, Yoshitaka
    Yamada, Yasuhide
    Terazawa, Tetsuji
    Takashima, Atsuo
    Iwasa, Satoru
    Kato, Ken
    Hamaguchi, Tetsuya
    Shimada, Yasuhiro
    Ohashi, Masaki
    Morita, Shinji
    Fukagawa, Takeo
    Machida, Nozomu
    Katai, Hitoshi
    SURGERY TODAY, 2016, 46 (09) : 1076 - 1082
  • [30] Feasibility of neoadjuvant S-1 and oxaliplatin followed by surgery for resectable advanced gastric adenocarcinoma
    Yoshitaka Honma
    Yasuhide Yamada
    Tetsuji Terazawa
    Atsuo Takashima
    Satoru Iwasa
    Ken Kato
    Tetsuya Hamaguchi
    Yasuhiro Shimada
    Masaki Ohashi
    Shinji Morita
    Takeo Fukagawa
    Nozomu Machida
    Hitoshi Katai
    Surgery Today, 2016, 46 : 1076 - 1082